1[1]Jarvis B,Simpson K.Clopidogrel:a review of its use in the prevention of atherothrombosis.Drugs,2000,60:347-377.
2[2]Steinhubl SR,Berger PB,Mann JT,et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial.JAMA,2002,20:2411-2420.
3[3]Jaremo P,Lindahl TL,Fransson SG,et al.Individual variations of platelet inhibition after loading doses of clopidogrel.J Intern Med,2002,252:233-238.
4[4]Mobley JE,Bresee SJ,Wortham DC,et al.Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization.Am J Cardiol,2004,93:456-458.
5[5]Davutoglu V,Soydinc S,Sezen Y.Complete lysis of left ventricular giant thrombus with fibrinolytic therapy in clopidogrel resistant patient.Thromb Thrombolysis,2003,15:59-63.
6[6]Lau WC,Gurbel PA,Watkins PB,et al.Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance.Circulation,2004,109:166-171.
7[7]Muller I,Besta F,Schulz C,et al.Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement.Thromb Haemost,2003,89:783-787.
8[8]Matetzky S,Shenkman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.Circulation,2004,109:3171-3175.
9[9]Gurbel PA,Samara WM,Bliden KP.Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting:implications for thrombotic events and restenosis.Platelets,2004,15:95-99.
10[10]Gaswaz M,Seyfarth M,Muller I,et al.Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.Am J Cardiol,2001,87:332-336.
